Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,454 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,230 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01324583 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | completed | Phase 1 | 48 | SanofiINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT01950871 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning(PHSTT-01) | terminated | Phase 4 | 80 | Advanced Medical Diagnostics s.a.INDUSTRY | 18 | Jan 5, 2015 | clinicaltrials |
| NCT00949338 | Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 | completed | N/A | 183 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00937833 | Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling | completed | N/A | 150 | Cook Group IncorporatedINDUSTRY | 1 | Dec 29, 2014 | clinicaltrials |
| NCT01244568 | Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 | completed | N/A | 218 | University of North Carolina, Chapel HillOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00666666 | R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01852864 | Degarelix Before Radical Prostatectomy | unknown | Early Phase 1 | 40 | University of CambridgeOTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT02064283 | Early Assessment of Treatment Response Using Functional Diffusion Mapping | completed | N/A | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01838265 | Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management(MGM) | withdrawn | — | 0 | University of MiamiOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01497431 | Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2014 | clinicaltrials |
| NCT01469338 | Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | terminated | Phase 2 | 9 | University of Southern CaliforniaOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT02292524 | Prostate Biomarkers in Men Consuming Tomato Products | completed | N/A | 33 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01601691 | Protection of Rectum From High Radiation Doses | completed | N/A | 10 | University of OuluOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT01610050 | A Phase I Study of LFA102 in Japanese Patients | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 11, 2014 | clinicaltrials |
| NCT01531205 | Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT00753220 | Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer(CRITICAL) | terminated | Phase 1 / Phase 2 | 7 | Bostwick LaboratoriesINDUSTRY | 1 | Nov 4, 2014 | clinicaltrials |
| NCT00918385 | Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer(ARS) | terminated | Phase 2 | 57 | Duke UniversityOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT00751205 | Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) | completed | Phase 2 | 150 | BayerINDUSTRY | 6 | Oct 28, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT01729442 | Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography(IDITOP-1) | completed | N/A | 30 | Hospices Civils de LyonOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT00683475 | A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer | completed | Phase 2 | 138 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01009736 | Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | completed | Phase 1 / Phase 2 | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01574846 | Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer(Vantas) | completed | — | 142 | Orion Corporation, Orion PharmaINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01749774 | Physical Activity and Testicular Cancer | completed | N/A | 13 | Oslo University HospitalOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01020305 | Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer | terminated | Phase 1 / Phase 2 | 5 | Sandy SrinivasOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT00459407 | Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2014 | clinicaltrials |
| NCT02258087 | HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.(PROMOBRA) | unknown | Phase 2 / Phase 3 | 50 | National Institute of Oncology, HungaryOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT02257827 | Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | completed | Phase 3 | 220 | Gustavo Viani ArrudaOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT01355185 | Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences | unknown | — | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT00705094 | Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients | completed | — | 30 | AHS Cancer Control AlbertaOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00103194 | Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01714219 | Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy | completed | N/A | 100 | Seoul National University HospitalOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01704027 | Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer | terminated | Phase 2 | 28 | Centre Georges Francois LeclercOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT02237612 | Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer | completed | N/A | 9 | University of Southern CaliforniaOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT01902251 | Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients | completed | Phase 1 | 27 | Astellas Pharma Europe B.V.INDUSTRY | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00801242 | Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer | completed | Phase 3 | 220 | Ferring PharmaceuticalsINDUSTRY | 6 | Sep 3, 2014 | clinicaltrials |
| NCT01177436 | Prostate Cancer Antigen 3 (PCA-3) Gene Project | completed | N/A | 31 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00323882 | Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 75 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00444730 | Urology Database for Outcomes Research | completed | — | 860 | Kenneth Peters, MDOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01484665 | Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening | completed | N/A | 72 | University of MinnesotaOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00385827 | A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) | terminated | Phase 2 | 106 | Centocor, Inc.INDUSTRY | 7 | Aug 20, 2014 | clinicaltrials |
| NCT01553838 | A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values | completed | N/A | 185 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Aug 19, 2014 | clinicaltrials |
| NCT00476645 | Fulvestrant in Hormone Refractory Prostate Cancer | completed | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT00672594 | Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy | completed | Phase 2 | 30 | Duke UniversityOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00815750 | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | completed | N/A | 147 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT01842750 | The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study(BRAD) | unknown | N/A | 10 | The Christie NHS Foundation TrustOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00004050 | Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer | terminated | Phase 2 | 13 | VicalINDUSTRY | 1 | Jul 29, 2014 | clinicaltrials |
| NCT00005072 | Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer | terminated | Phase 1 / Phase 2 | 25 | VicalINDUSTRY | 1 | Jul 29, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Jan 8, 2015source: clinicaltrials